Rocket Pharmaceuticals, Inc. (NASDAQ:RCKTW) Short Interest Update

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKTW) was the recipient of a significant drop in short interest during the month of April. As of April 15th, there was short interest totalling 100 shares, a drop of 98.4% from the March 31st total of 6,200 shares. Based on an average daily volume of 21,900 shares, the days-to-cover ratio is presently 0.0 days.

Rocket Pharmaceuticals Stock Up 20.7 %

Rocket Pharmaceuticals stock traded up $0.02 during midday trading on Thursday, hitting $0.11. 6,589 shares of the company were exchanged, compared to its average volume of 24,998. Rocket Pharmaceuticals has a fifty-two week low of $0.05 and a fifty-two week high of $0.50. The business has a fifty day simple moving average of $0.24 and a two-hundred day simple moving average of $0.29.

About Rocket Pharmaceuticals

Rocket Pharmaceuticals, Inc, together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells or promotes the production of faulty blood cells; leukocyte adhesion deficiency-I, a genetic disorder that causes the immune system to malfunction; and pyruvate kinase deficiency, a rare red blood cell autosomal recessive disorder that results in chronic non-spherocytic hemolytic anemia.